GEA’s factory in Elsdorf sets new standards in pharmaceutical production
|
EQS-News: GEA Group Aktiengesellschaft
/ Key word(s): Miscellaneous
GEA’s factory in Elsdorf sets new standards in pharmaceutical production
Düsseldorf, March 22, 2024 – Construction of GEA’s new pharmaceutical technology center in Elsdorf, Germany, begins today – setting new industry benchmarks. The machinery and plant manufacturer is investing EUR 80 million in the new freeze-drying systems facility. These systems are used in the production of numerous injectable pharmaceuticals, including vaccines. The new facility is scheduled to open in the second half of 2025. With people increasingly aware of the major role immunization plays in preventing disease, the market for vaccines is growing rapidly worldwide. In order to meet this rising demand, GEA opted to build a new plant, as capacities at the existing facility in Hürth were nearing their limits. All 250 employees are to relocate to the new plant. “This investment will open the door to our onward growth as well as improved innovation opportunities in the pharmaceutical sector, which is strategically significant for us. The new plant will enable us to align even more closely with our customers’ needs and expand our leading market position,” says GEA CEO Stefan Klebert. Construction starts on GEA’s second “Factory of the Future” covering over 40,000 m² Following the opening of the first factory in Poland in 2022, the second plant of its kind – covering an area of over 40,000 m² – is now being built in Germany. At Elsdorf, state-of-the-art processes and working methods as well as the associated digitalization are the main focus alongside sustainable construction. Mobile devices coupled with the use of apps for production control and monitoring will help create an ergonomic and attractive workplace for employees. End-to-end document management and digital workflows will ensure efficient and targeted access to company-relevant information. Reliable material tracking will be made possible by the intelligent warehouse management system. “With modular manufacturing structures and digital technologies that make our production more flexible and faster, we are setting new standards in the GEA network,” says GEA COO Johannes Giloth. New facility meets the highest sustainability standards “We develop sustainable solutions for the food and pharmaceutical industries to help protect future generations. So we need to reflect this also in our own actions. Ultimately, only an industrial base with a firm focus on sustainability will remain competitive and strong on exports going forward,” adds CEO Stefan Klebert. This is why the new pharmaceutical technology center is going to be built according to the highest sustainability standards. Power will be generated by the company’s own photovoltaic system. The electricity will be stored in batteries to keep it available for charging electric vehicles, for example. No natural gas will be used. Heat recovered in system test runs can be used to heat and cool the plant. A green roof will provide protection against hot weather for the building and employees as well as create pleasant air quality. A water retention system and minimum soil sealing will ensure that annual rainfall is used and distributed to optimum effect. Biodiversity at the site will be promoted by the green roof and an ecological compensation area on the property. A strong signal for Elsdorf as a business location For the town of Elsdorf, about half an hour’s drive from Hürth in the Rhein-Erft district, the new plant is an important signal of its importance as a business location. "We warmly welcome GEA to our town and are delighted that the company has chosen Elsdorf. This shows once again how attractive Elsdorf and our region are as a business location. With the construction of the new GEA plant, we are getting a further important boost for structural change, as future-proof and valuable jobs will be located in our town. Our hard work is now bearing further fruit,” says Mayor Andreas Heller.
NOTE TO EDITORS
Media Relations
About GEA GEA is one of the world’s largest suppliers of systems and components to the food, beverage and pharmaceutical industries. The international technology group, founded in 1881, focuses on machinery and plants, as well as advanced process technology, components and comprehensive services. With more than 18,000 employees, the group generated revenues of about EUR 5.4 billion in more than 150 countries in the 2023 fiscal year. GEA plants, processes, components and services enhance the efficiency and sustainability of customer’s production. They contribute significantly to the reduction of CO2 emissions, plastic usage and food waste. In doing so, GEA makes a key contribution toward a sustainable future, in line with the company’s purpose: ”Engineering for a better world“. GEA is listed on the German MDAX the European STOXX® Europe 600 Index and is among the companies comprising
22.03.2024 CET/CEST Dissemination of a Corporate News, transmitted by EQS News - a service of EQS Group AG. |
| Language: | English |
| Company: | GEA Group Aktiengesellschaft |
| Peter-Müller-Straße 12 | |
| 40468 Düsseldorf | |
| Germany | |
| Phone: | +49 (0)211 9136-0 |
| E-mail: | ir@gea.com |
| Internet: | www.gea.com |
| ISIN: | DE0006602006 |
| WKN: | 660200 |
| Indices: | MDAX |
| Listed: | Regulated Market in Berlin, Dusseldorf, Frankfurt (Prime Standard), Hamburg, Munich; Regulated Unofficial Market in Hanover, Stuttgart, Tradegate Exchange |
| EQS News ID: | 1865469 |
| End of News | EQS News Service |
|
|
1865469 22.03.2024 CET/CEST
P R O D U C T S U G G E S T I O N S
The information presented here has been provided by our content partner EQS-Group. The originator of the news is the respective issuer, the company relating to the news, a publication service provider (press or information agency) which uses the distribution service of EQS to transmit company news to shareholders, investors, investors or interested parties. The original publications and other company-relevant information can be found at eqs-news.com.
The information you can access does not constitute investment advice. The presentation of our cooperation partners, where the implementation of investment decisions would be possible depending on the individual risk profile, is solely at the discretion of the person using the service. We only present companies of which we are convinced that the range of services and customer service will satisfy discerning investors.
If you are considering leverage products, familiarise yourself with the typical characteristics of the financial instruments beforehand. Take the time to determine the risk content of the planned investment before making an investment decision. Bear in mind that a total loss cannot be ruled out with leverage products.
For newcomers to the subject, we offer various options in both the training and the tools section, through which you can train theoretical knowledge and practical experience and thus improve your skills. The offer ranges from participation in webinars to personal mentoring. The range is continuously being expanded.
1 Lab features are usually functionalities that emerge from the think tank of the investor community. In the early stages, these are experimental functionalities whose development process is largely determined by use and the resulting feedback from the community. When integrating external services or functionalities, the functionality can only be guaranteed to the extent that the individual process elements, such as interfaces, interact with each other.